10.1006/clim.1998.4636
Crossref journal-article
Elsevier BV
Clinical Immunology (78)
Bibliography

Chiarle, R., Podda, A., Prolla, G., Gong, J., Thorbecke, G. J., & Inghirami, G. (1999). CD30 in Normal and Neoplastic Cells. Clinical Immunology, 90(2), 157–164.

Authors 6
  1. Roberto Chiarle (first)
  2. Antonello Podda (additional)
  3. Gabriel Prolla (additional)
  4. Jerry Gong (additional)
  5. G.Jeanette Thorbecke (additional)
  6. Giorgio Inghirami (additional)
References 101 Referenced 143
  1. 10.1182/blood.V66.4.848.848 / Blood / The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed–Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells by Stein (1985)
  2. {'key': '10.1006/clim.1998.4636_RF2', 'series-title': 'Neoplastic Hematopathology', 'author': 'Stein', 'year': '1992'} / Neoplastic Hematopathology by Stein (1992)
  3. 10.1016/0092-8674(94)90372-7 / Cell / The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death by Smith (1994)
  4. 10.1182/blood.V85.12.3378.bloodjournal85123378 / Blood / Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas by Gruss (1995)
  5. 10.1016/0092-8674(92)90180-K / Cell / Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease by Durkop (1992)
  6. 10.4049/jimmunol.139.6.2081 / J. Immunol. / Biochemical characterization and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines by Froese (1987)
  7. 10.1515/bchm3.1989.370.1.409 / Biol. Chem. Hoppe Seyler / The Hodgkin-associated Ki-1 antigen exists in an intracellular and a membrane-bound form by Hansen (1989)
  8. 10.1074/jbc.271.22.12852 / J. Biol. Chem. / CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins by Gedrich (1996)
  9. 10.1073/pnas.93.18.9699 / Proc. Natl. Acad. Sci. USA / CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity by Lee (1996)
  10. 10.1074/jbc.272.4.2042 / J. Biol. Chem. / Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation by Aizawa (1997)
  11. 10.1093/intimm/10.2.203 / Int. Immunol. / A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation by Horie (1998)
  12. 10.1002/ijc.2910630524 / Int. J. Cancer / A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines by Hansen (1995)
  13. 10.1002/ijc.2910600419 / Int. J. Cancer / Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4) by Horn-Lohrens (1995)
  14. {'key': '10.1006/clim.1998.4636_RF14', 'first-page': '3353', 'article-title': 'Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells', 'volume': '52', 'author': 'Gruss', 'year': '1992', 'journal-title': 'Cancer Res.'} / Cancer Res. / Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells by Gruss (1992)
  15. 10.1182/blood.V83.8.2045.2045 / Blood / Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines by Gruss (1994)
  16. 10.1002/eji.1830251024 / Eur. J. Immunol. / CD30 ligation induces nuclear factor-kappa B activation in human T cell lines by McDonald (1995)
  17. 10.1128/MCB.17.3.1535 / Mol. Cell. Biol. / Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2 by Duckett (1997)
  18. 10.4049/jimmunol.151.11.5896 / J. Immunol. / Functional effects of CD30 on a large granular lymphoma cell line, YT by Bowen (1993)
  19. 10.1016/1074-7613(95)90003-9 / Immunity / Cross-linking of CD30 induces HIV expression in chronically infected T cells by Biswas (1995)
  20. 10.1182/blood.V88.7.2422.bloodjournal8872422 / Blood / A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages by Horie (1996)
  21. 10.1016/0092-8674(93)90132-A / Cell / Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: Implications for TNF receptor activation by Banner (1993)
  22. 10.1002/jlb.63.6.752 / J. Leukoc. Biol. / Construction and expression of a soluble form of human CD30 ligand with functional activity by Powell (1998)
  23. 10.4049/jimmunol.156.2.442 / J. Immunol. / Structure and expression of murine CD30 and its role in cytokine production by Bowen (1996)
  24. Chiarle, R. Podda, A. Prolla, G. Podack, E. R. Thorbecke, G. J. Inghirami, G. CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a caspase and Bcl-2 sensitive pathway, Submitted.
  25. 10.4049/jimmunol.160.5.2180 / J. Immunol. / Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines by Gilfillan (1998)
  26. 10.1016/S0378-1119(96)00542-2 / Gene / Cloning and characterization of a cDNA for rat CD30 homolog and chromosomal assignment of the genomic gene by Aizawa (1996)
  27. 10.1136/jcp.39.9.993 / J. Clin. Pathol. / High proliferative activity of Reed Sternberg associated antigen Ki-1 positive cells in normal lymphoid tissue by Gerdes (1986)
  28. 10.1182/blood.V90.6.2445 / Blood / BCL-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30+ anaplastic large-cell lymphomas by Carbone (1997)
  29. 10.1182/blood.V91.9.3323 / Blood / High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus by Romagnani (1998)
  30. 10.4049/jimmunol.157.8.3229 / J. Immunol. / CD30 expression on human CD8+ T cells isolated from peripheral blood lymphocytes of normal donors by Agrawal (1996)
  31. 10.1111/j.1365-2141.1993.tb03166.x / Br. J. Haematol. / Cultured human NK cells express the Ki-1/CD30 antigen by Cambiaggi (1993)
  32. 10.1111/j.1365-2559.1993.tb00476.x / Histopathology / Expression of CD30 and nerve growth factor-receptor in neoplastic and reactive vascular lesions: An immunohistochemical study by Rudolph (1993)
  33. {'key': '10.1006/clim.1998.4636_RF33', 'first-page': '276', 'article-title': 'High expression of the CD30 molecule in human decidual cells', 'volume': '145', 'author': 'Ito', 'year': '1994', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / High expression of the CD30 molecule in human decidual cells by Ito (1994)
  34. 10.4049/jimmunol.151.5.2380 / J. Immunol. / CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells by Ellis (1993)
  35. 10.1016/S0092-8674(00)81031-4 / Cell / Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice by Amakawa (1996)
  36. 10.4049/jimmunol.158.5.2090 / J. Immunol. / Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma by Nakamura (1997)
  37. 10.1002/eji.1830250742 / Eur. J. Immunol. / Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed–Sternberg cells by Gruss (1995)
  38. 10.1084/jem.180.6.2407 / J. Exp. Med. / CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection by Manetti (1994)
  39. 10.1084/jem.182.6.1655 / J. Exp. Med. / CD30-mediated signaling promotes the development of human T helper type 2-like T cells by Del Prete (1995)
  40. 10.1159/000237532 / Int. Arch. Allergy Immunol. / An update on human Th1 and Th2 cells by Romagnani (1997)
  41. 10.1002/jlb.58.6.683 / J. Leukoc. Biol. / Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation by Bengtsson (1995)
  42. 10.4049/jimmunol.156.4.1387 / J. Immunol. / CD30 expression does not discriminate between human Th1- and Th2-type T cells by Hamann (1996)
  43. 10.1093/intimm/9.5.713 / Int. Immunol. / Human CD30+ cells are induced by Mycobacterium tuberculosis and present in tuberculosis lesions by Munk (1997)
  44. 10.4049/jimmunol.153.7.2861 / J. Immunol. / CD30 defines a subset of activated human T cells that produce IFN-gamma and IL-5 and exhibit enhanced B cell helper activity by Alzona (1994)
  45. 10.4049/jimmunol.154.1.9 / J. Immunol. / IL-12 activates IFN-gamma production through the preferential activation of CD30+ T cells by Alzona (1995)
  46. 10.1002/eji.1830260209 / Eur. J. Immunol. / CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2-mediated condition by Chilosi (1996)
  47. {'key': '10.1006/clim.1998.4636_RF47', 'first-page': '339', 'article-title': 'Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity', 'volume': '13', 'author': 'Caligaris-Cappio', 'year': '1995', 'journal-title': 'Clin. Exp. Rheumatol.'} / Clin. Exp. Rheumatol. / Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity by Caligaris-Cappio (1995)
  48. 10.1111/j.1365-2249.1995.tb03851.x / Clin. Exp. Immunol. / High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints by Gerli (1995)
  49. 10.1016/S0002-9343(97)00049-1 / Am. J. Med. / High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis by Wang (1997)
  50. {'key': '10.1006/clim.1998.4636_RF50', 'first-page': '1751', 'article-title': 'Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis', 'volume': '151', 'author': 'Mavalia', 'year': '1997', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis by Mavalia (1997)
  51. 10.1046/j.1365-2249.1996.d01-823.x / Clin. Exp. Immunol. / Spontaneous CD30 mRNA expression in peripheral blood mononuclear cells from atopic patients with high IgE serum levels by Esnault (1996)
  52. 10.1001/archderm.1996.03890340031006 / Arch. Dermatol. / Circulating skin-homing T cells in atopic dermatitis by Piletta (1996)
  53. 10.1128/JVI.72.4.3138-3145.1998 / J. Virol. / Herpesvirus saimiri transforms human T-cell clones to stable growth without inducing resistance to apoptosis by Kraft (1998)
  54. 10.4049/jimmunol.159.2.1012 / J. Immunol. / CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes by Woitas (1997)
  55. 10.1046/j.1365-2249.1996.915607.x / Clin. Exp. Immunol. / Serum levels of soluble CD30 in chronic hepatitis B virus infection by Fattovich (1996)
  56. 10.1046/j.1365-2249.1997.d01-1005.x / Clin. Exp. Immunol. / High serum level of soluble CD30 in acute primary HIV-1 infection by Pizzolo (1997)
  57. {'key': '10.1006/clim.1998.4636_RF57', 'first-page': '43', 'article-title': 'Soluble CD30, tumour necrosis factor (TNF)-alpha, and TNF receptors in primary HIV-1 infection: Relationship with HIV-1, RNA, clinical outcome and early antiviral therapy', 'volume': '11', 'author': 'Rizzardi', 'year': '1997', 'journal-title': 'J. Biol. Regul. Homeost. Agents'} / J. Biol. Regul. Homeost. Agents / Soluble CD30, tumour necrosis factor (TNF)-alpha, and TNF receptors in primary HIV-1 infection: Relationship with HIV-1, RNA, clinical outcome and early antiviral therapy by Rizzardi (1997)
  58. 10.1097/00002030-199611000-00001 / Aids / Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: Correlation with HIV-1 RNA and the clinical outcome by Rizzardi (1996)
  59. 10.1016/1074-7613(95)90094-2 / Immunity / Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals by Maggi (1995)
  60. 10.1073/pnas.94.4.1390 / Proc. Natl. Acad. Sci. USA / CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2 by Tsitsikov (1997)
  61. {'key': '10.1006/clim.1998.4636_RF61', 'first-page': '463', 'article-title': 'CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule', 'volume': '146', 'author': 'Latza', 'year': '1995', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule by Latza (1995)
  62. 10.1016/0046-8177(94)90125-2 / Hum. Pathol. / Ber-H2 expression in testicular germ cell tumors by Ferreiro (1994)
  63. 10.1016/S0046-8177(96)90310-X / Hum. Pathol. / CD30 expression in seminoma by Hittmair (1996)
  64. 10.1111/j.1699-0463.1998.tb01332.x / Apmis / CD30 and its ligand: possible role in regulation of teratoma stem cells by Pera (1998)
  65. {'key': '10.1006/clim.1998.4636_RF65', 'first-page': '291', 'article-title': "The distinction of Hodgkin's disease from anaplastic large cell lymphoma", 'volume': '9', 'author': 'Frizzera', 'year': '1992', 'journal-title': 'Semin. Diagn. Pathol.'} / Semin. Diagn. Pathol. / The distinction of Hodgkin's disease from anaplastic large cell lymphoma by Frizzera (1992)
  66. 10.1111/j.1365-2559.1989.tb02198.x / Histopathology / Lymphoma phenotyping in formalin-fixed and paraffin wax-embedded tissues: II by Norton (1989)
  67. 10.1097/00000478-199405000-00014 / Am. J. Surg. Pathol. / Nodular lymphocyte predominance Hodgkin's disease by Mason (1994)
  68. 10.1073/pnas.91.23.10962 / Proc. Natl. Acad. Sci. USA / Hodgkin disease: Hodgkin and Reed–Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development by Kuppers (1994)
  69. 10.1073/pnas.94.17.9337 / Proc. Natl. Acad. Sci. USA / Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells by Braeuninger (1997)
  70. 10.1056/NEJM199708143370704 / N. Engl. J. Med. / Clonality in nodular lymphocyte-predominant Hodgkin's disease [see comments by Ohno (1997)
  71. 10.1056/NEJM199708143370703 / N. Engl. J. Med. / Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells [see Comments] by Marafioti (1997)
  72. 10.1182/blood.V87.2.465.bloodjournal872465 / Blood / Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease by Falini (1996)
  73. 10.1182/blood.V86.1.45.bloodjournal86145 / Blood / BCL-6 protein is expressed in germinal-center B cells by Cattoretti (1995)
  74. 10.1182/blood.V86.1.28.bloodjournal86128 / Blood / BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts by Onizuka (1995)
  75. 10.1111/j.1365-2141.1990.tb02664.x / Br. J. Haematol. / Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: Relationship with disease activity and clinical stage by Pizzolo (1990)
  76. 10.1182/blood.V77.9.1983.1983 / Blood / Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease by Gause (1991)
  77. 10.1182/blood.V91.8.3011.3011_3011_3016 / Blood / Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome by Nadali (1998)
  78. 10.1200/JCO.1995.13.6.1355 / J. Clin. Oncol. / Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphoma by Nadali (1995)
  79. 10.1111/j.1365-2141.1992.tb08208.x / Br. J. Haematol. / Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: In vitro evaluation by Tazzari (1992)
  80. 10.1182/blood.V85.8.2139.bloodjournal8582139 / Blood / Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma by Pasqualucci (1995)
  81. 10.4049/jimmunol.155.5.2369 / J. Immunol. / Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands by Jumper (1995)
  82. 10.1056/NEJM198902233200806 / N. Engl. J. Med. / Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease by Weiss (1989)
  83. 10.1073/pnas.88.11.4766 / Proc. Natl. Acad. Sci. USA / Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells by Herbst (1991)
  84. 10.1128/jvi.65.1.415-423.1991 / J. Virol. / Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene by Zimber-Strobl (1991)
  85. 10.1136/jcp.47.1.33 / J. Clin. Pathol. / Relation of CD30 expression to survival and morphology in large B cell lymphomas by Noorduyn (1994)
  86. 10.1002/1097-0142(19930315)71:6<2097::AID-CNCR2820710626>3.0.CO;2-7 / Cancer / Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis by Beljaards (1993)
  87. 10.1084/jem.183.2.669 / J. Exp. Med. / T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors by Lee (1996)
  88. 10.1182/blood.V87.6.2443.bloodjournal8762443 / Blood / Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor by Gruss (1996)
  89. 10.1615/CritRevOncog.v5.i5.30 / Crit. Rev. Oncog. / Hodgkin's disease: A cytokine-producing tumor—A review by Gruss (1994)
  90. 10.1182/blood.V84.7.2305.2305 / Blood / Expression and function of CD40 on Hodgkin and Reed–Sternberg cells and the possible relevance for Hodgkin's disease by Gruss (1994)
  91. 10.1016/S1074-7613(00)80390-8 / Immunity / TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival by Lee (1997)
  92. 10.1016/S1074-7613(00)80391-X / Immunity / Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice by Yeh (1997)
  93. 10.1016/1074-7613(95)90113-2 / Immunity / A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection by Calnan (1995)
  94. 10.1084/jem.185.7.1275 / J. Exp. Med. / TRAF-interacting protein (TRIP): A novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation by Lee (1997)
  95. 10.1101/gad.11.21.2810 / Genes Dev. / CD30-dependent degradation of TRAF2: Implications for negative regulation of TRAF signaling and the control of cell survival by Duckett (1997)
  96. 10.1016/S1074-7613(00)80607-X / Immunity / CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells by Cerutti (1998)
  97. 10.1002/eji.1830250805 / Eur. J. Immunol. / Regulation of murine B cell growth and differentiation by CD30 ligand by Shanebeck (1995)
  98. 10.4049/jimmunol.157.8.3635 / J. Immunol. / Reverse signaling via CD30 ligand by Wiley (1996)
  99. 10.1016/S0167-5699(97)84661-0 / Immunol. Today / Hodgkin's disease: a tumor with disturbed immunological pathways by Gruss (1997)
  100. 10.1182/blood.V88.9.3299.bloodjournal8893299 / Blood / Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line by Pinto (1996)
  101. {'key': '10.1006/clim.1998.4636_RF101', 'first-page': '469', 'article-title': "CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues", 'volume': '149', 'author': 'Gruss', 'year': '1996', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues by Gruss (1996)
Dates
Type When
Created 22 years, 10 months ago (Oct. 6, 2002, 3:13 p.m.)
Deposited 2 years, 5 months ago (April 4, 2023, 12:22 p.m.)
Indexed 4 months, 1 week ago (April 24, 2025, 1:47 a.m.)
Issued 26 years, 7 months ago (Feb. 1, 1999)
Published 26 years, 7 months ago (Feb. 1, 1999)
Published Print 26 years, 7 months ago (Feb. 1, 1999)
Funders 0

None

@article{Chiarle_1999, title={CD30 in Normal and Neoplastic Cells}, volume={90}, ISSN={1521-6616}, url={http://dx.doi.org/10.1006/clim.1998.4636}, DOI={10.1006/clim.1998.4636}, number={2}, journal={Clinical Immunology}, publisher={Elsevier BV}, author={Chiarle, Roberto and Podda, Antonello and Prolla, Gabriel and Gong, Jerry and Thorbecke, G.Jeanette and Inghirami, Giorgio}, year={1999}, month=feb, pages={157–164} }